VacV is a cancer immunotherapy company developing viral-based therapies for cancer. Their versatile technology uses a novel oncolytic Vaccinia virus and is designed to create efficacious and safe treatments.

VacV’s promising pipeline of easy-to-administer treatments includes features that offer significant advantages compared to existing treatment options.